Is residual myocardial iron following intramyocardial hemorrhage associated with adverse left ventricular remodeling in reperfused STEMI patients?
Residual myocardial iron following intramyocardial hemorrhage in reperfused STEMI patients is associated with adverse LV remodeling, highlighting it as a potential therapeutic target.
The majority of ST-segment-elevation myocardial infarction patients with IMH had residual myocardial iron at follow-up. This was associated with persistently elevated T2 values in the surrounding infarct tissue and adverse LV remodeling. IMH and residual myocardial iron may be potential therapeutic targets for preventing adverse LV remodeling in reperfused ST-segment-elevation myocardial infarction patients.
Bulluck et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: